GNS Healthcare

Dec 12, 2017

GNS Healthcare Uses Causal AI to Discover Which Multiple Myeloma Patients Will Have Progression Free Survival Benefit from Stem Cell Treatments

Nov 08, 2017

GNS Healthcare Names Dr. David Sontag to its Strategic Advisory Board

Sep 26, 2017

AI-Driven Discovery of Novel Predictors of Parkinson's Disease Progression by GNS Healthcare Appears in The Lancet Neurology

Sep 13, 2017

GNS Healthcare and Swedish Cancer Institute Launch Machine Learning Collaboration to Strengthen Delivery of Precision Medicine in Breast Cancer Care

Aug 23, 2017

Amgen Ventures Invests in GNS Healthcare to Advance Applications of its REFS(TM) Causal Machine Learning and Simulation AI Platforms

Aug 10, 2017

GNS Healthcare Licenses REFS(TM) Causal Machine Learning and Simulation Platform to Alexion to Accelerate Discovery of New Treatments for Rare Diseases

Jun 19, 2017

GNS Healthcare Announces Collaboration to Power Cancer Drug Development with REFS(TM) Causal Machine Learning and Simulation AI Platform

May 31, 2017

GNS Healthcare Uncovers Novel Targets for Triple-Negative Breast Cancer Using Causal Machine Learning and Simulation Platform REFS(TM)